Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4890618 | 0.94 | TSHR (0.36) | TSHRALDH1A1HPGD | |
| SCHEMBL168359 | 0.87 | TSHR (0.53) | TSHRALDH1A1HPGDTDP1 | |
| SCHEMBL4885631 | 0.86 | TSHR (0.33) | TSHR | |
| SCHEMBL2046400 | 0.85 | TSHR (0.48) | TSHRALDH1A1HPGDTDP1 | |
| SCHEMBL35691 | 0.83 | LMNA (0.38) | TDP1 | |
| SCHEMBL4891419 | 0.82 | TSHR (0.35) | TSHRALDH1A1HPGD | |
| SCHEMBL4891948 | 0.80 | TSHR (0.33) | TSHR | |
| SCHEMBL19699816 | 0.79 | HCAR2 (0.52) | TSHRALDH1A1HPGDTDP1 | |
| SCHEMBL19699814 | 0.79 | HCAR2 (0.52) | TSHRALDH1A1HPGDTDP1 | |
| SCHEMBL10530524 | 0.78 | TSHR (0.45) | TSHRALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 153 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023194367-A1 | TWO-PART CURABLE COMPOSITION | BOSTIK SA (FR) | 2023-10-12 | — | — | WO | claimed |
| EP-4257648-A1 | TWO-PART CURABLE COMPOSITION | Bostik SA (FR) | 2023-10-11 | — | — | EP | claimed |
| US-20220185929-A1 | TWO-PART CURABLE COMPOSITION | BOSTIK SA (FR) | 2022-06-16 | — | — | US | claimed |
| EP-3941987-A1 | TWO-PART CURABLE COMPOSITION | Bostik SA (FR) | 2022-01-26 | — | — | EP | claimed |
| WO-2020187963-A1 | TWO-PART CURABLE COMPOSITION | BOSTIK SA (FR) | 2020-09-24 | — | — | WO | claimed |
| EP-3191561-B1 | FAST AND ELASTIC ADHESIVE | AFINITICA TECH S L (ES) | 2020-05-06 | — | — | EP | claimed |
| US-10626299-B2 | Fast and elastic adhesive | AFINITICA TECHNOLOGIES, S.L. (ES) | 2020-04-21 | — | — | US | claimed |
| EP-2995664-B1 | Fast and universal adhesive | AFINITICA TECH S L (ES) | 2019-08-28 | — | — | EP | claimed |
| US-20170260422-A1 | FAST AND ELASTIC ADHESIVE | AFINITICA TECHNOLOGIES, S. L. (ES) | 2017-09-14 | — | — | US | claimed |
| EP-3191561-A1 | FAST AND ELASTIC ADHESIVE | Afinitica Technologies, S. L. (ES) | 2017-07-19 | — | — | EP | claimed |
| WO-2016038514-A1 | FAST AND ELASTIC ADHESIVE | AFINITICA TECHNOLOGIES, S. L. (ES) | 2016-03-17 | — | — | WO | claimed |
| EP-2995663-A1 | Fast and elastic adhesive | Afinitica Technologies, S. L. (ES) | 2016-03-16 | — | — | EP | claimed |
| EP-2995664-A1 | Fast and universal adhesive | Afinitica Technologies, S. L. (ES) | 2016-03-16 | — | — | EP | claimed |
| US-20100112036-A1 | Cyanoacrylate-based liquid microbial sealant drape | ADHEZION BIOMEDICAL, LLC. (US) | 2010-05-06 | — | — | US | claimed |
| WO-2010051445-A2 | CYANOACRYLATE-BASED LIQUID MICROBIAL SEALANT DRAPE | ADHEZION BIOMEDICAL, LLC. (US) | 2010-05-06 | — | — | WO | claimed |
| US-20070248560-A1 | Cosmetic product comprising at least one cyanoacrylate monomer and at least one non-ionic polyurethane | L'OREAL S.A. (FR) | 2007-10-25 | — | — | US | claimed |
| US-5665107-A | Surface opening adhesive sealer | HEMODYNAMICS, INC. (US) | 1997-09-09 | — | — | US | claimed |
| US-5653730-A | Surface opening adhesive sealer | HEMODYNAMICS, INC. (US) | 1997-08-05 | — | — | US | claimed |
| US-5529577-A | Surface opening adhesive sealer | HEMODYNAMICS, INC. (US) | 1996-06-25 | — | — | US | claimed |
| US-5383899-A | Method of using a surface opening adhesive sealer | HEMODYNAMICS, INC. | 1995-01-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070248560-A1 | Cosmetic product comprising at least one cyanoacrylate monomer and at least one non-ionic polyurethane | KRT18, CUTA, DSG1 | TSHR 4475/4885ALDH1A1 307/4885HPGD 467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.